COTHERIX
Cotherix is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, our lead product candidate, is an inhaled formulation of iloprost.
COTHERIX
Industry:
Biotechnology Finance Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.cotherix.com
Total Employee:
51+
Status:
Active
Total Funding:
55 M USD
Technology used in webpage:
SSL By Default Google Font API Google Tag Manager Euro Amazon AJAX Libraries API Sectigo SSL Amazon S3 Amazon CloudFront Sectigo Organization SSL
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Onspira Therapeutics
Onspira Therapeutics operates as a clinical-stage biopharmaceutical company.
Theratechnologies
Theratechnologies is a a bio-pharmaceutical company, engages in the discovery of therapeutic products for commercialisation.
VECTOR STRATEGIC ADVISORS LLC
Boutique business development strategy and execution and fund raising for the biopharmaceutical sector.
Current Advisors List
Founder
Stock Details
Investors List
Alta Partners
Alta Partners investment in Series C - Cotherix
Sofinnova Partners
Sofinnova Partners investment in Series C - Cotherix
Spray Venture Partners
Spray Venture Partners investment in Series C - Cotherix
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series C - Cotherix
MPM Capital
MPM Capital investment in Series C - Cotherix
Vivo Capital
Vivo Capital investment in Series C - Cotherix
Sofinnova Investments
Sofinnova Investments investment in Series C - Cotherix
Thomas Weisel Venture Partners
Thomas Weisel Venture Partners investment in Series C - Cotherix
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Cotherix
